Liquid Picosulfate Formulation Stabilized for Immediate Dosing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing formulations of picosulfate, particularly those combined with magnesium oxide and citric acid, do not dissolve immediately and require stirring, risking incomplete dosing if not stirred properly, and picosulfate formulations are unstable when stored or allowed to stand.

Innovation Solution

Development of stable liquid formulations containing picosulfate with an antioxidant, such as sodium metabisulfite, to maintain stability for extended periods, allowing for immediate use without stirring.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If picosulfate is formulated as a solid preparation requiring dissolution, then the formulation can be stored stably, but the patient must stir for 2-3 minutes to ensure complete dissolving, risking incomplete dosing

Engineering Contradiction:
Improvedosing completenessVSAvoidpatient operation complexity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent changes the physical state parameter from solid to liquid formulation. The liquid formulation contains picosulfate, magnesium citrate, and antioxidant already dissolved in water, eliminating the need for patient stirring while ensuring complete dosing. This parameter change directly resolves the contradiction between dosing completeness and operation simplicity.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If liquid formulation containing picosulfate is prepared immediately for use, then immediate administration is possible, but the formulation is unstable and degrades when stored

Engineering Contradiction:
Improveimmediate use capabilityVSAvoidformulation stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent introduces an antioxidant (such as sodium metabisulfite, ascorbic acid, or other reducing agents) as an intermediary substance that protects picosulfate from oxidation and degradation. This intermediary stabilizes the liquid formulation during storage while maintaining its immediate use capability, resolving the contradiction between stability and immediate use.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical stability parameter by adjusting pH (maintaining between 4.0-6.5) and adding antioxidants. These parameter changes enable the liquid formulation to remain stable during storage while still allowing immediate administration without degradation.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If solid picosulfate preparation is used, then storage stability is maintained, but the formulation does not dissolve immediately and requires patient stirring

Engineering Contradiction:
Improveformulation stabilityVSAvoiddissolution speed
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

The patent changes the physical state from solid to liquid and pre-dissolves all components (picosulfate, magnesium citrate, and antioxidants) during manufacturing. This parameter change achieves immediate dissolution upon administration while maintaining formulation stability through controlled storage conditions and antioxidant protection.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulations remain stable for at least 10 days to 2 years, maintaining effectiveness and ensuring complete dosing by preventing degradation and precipitation.

Implementation Method 1

formulations containing picosulfate, e.g., sodium picosulfate, are unstable when stored or allowed to stand

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

the products include citric acid, magnesium oxide, and sodium picosulfate, as active ingredients

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Data Source

PatentUS20260014128A1Stabilized liquid formulations containing picosulfate
Publication Date: 2026.01.15 FERRING BV
  • US20260014128A1 patent drawing
  • US20260014128A1 patent drawing
  • US20260014128A1 patent drawing

AI summary

Stable liquid formulations containing picosulfate and magnesium citrate are provided. The formulations are useful to treat constipation or for the clearance of the bowel prior to X-ray examination, endoscopy or surgery.